Countermeasures Against Prescription and Over-the-Counter Drug-Impaired Driving
archive: archived pipeline: cataloged verified
Get this paper ↗ (full text — opens at the source; we link to it, we don't host it)
Summary
This report addresses the significant traffic safety concern of driving under the influence of prescription and over-the-counter (OTC) drugs, a problem exacerbated by the high prevalence of such drug use among drivers. While alcohol-impaired driving has been extensively studied, there is a critical lack of research regarding the specific effects of prescription and OTC medications on driving performance and the efficacy of countermeasures designed to mitigate this risk. The study was motivated by data indicating that up to 13% of daytime drivers test positive for potentially impairing prescription or OTC drugs, yet existing reviews often focus on illegal drugs or alcohol, leaving a gap in evidence-based strategies for legally obtained medications. To fill this gap, the authors conducted a comprehensive assessment of the current state of knowledge using four interconnected methods: a systematic literature review, an expert roundtable, targeted subject matter expert interviews, and an evaluation of existing data sources. The literature review screened over 16,000 references from multiple databases, identifying more than 200 relevant sources. The expert roundtable and interviews engaged 17 leading experts from domains including law enforcement, toxicology, medicine, and pharmacy to identify unpublished countermeasures, assess feasibility, and provide insights into implementation challenges. Countermeasures were categorized into four domains: pharmacy and medical, data recording and toxicology, law enforcement and judicial, and education and advertising. The study identified approximately 60 specific countermeasures but found a general lack of empirical support and published research validating their effectiveness. A primary challenge identified is the difficulty in predicting impairment due to individual differences in drug effects and the prevalence of polydrug usage, which complicates the establishment of per se limits similar to blood alcohol concentration. The report highlights that drivers often lack the knowledge to distinguish between impairing and non-impairing medications, and healthcare professionals may be unaware of the severity of the issue. Consequently, the authors emphasize that countermeasures must target not only drivers but also the professionals who interact with them, such as pharmacists and physicians. The significance of this work lies in its identification of promising areas for intervention, including patient counseling, improved prescription labeling, the implementation of new technologies like oral fluid drug testing, and increased coordination across the legal system. The report concludes that addressing prescription and OTC drug-impaired driving requires a multifaceted approach involving better information on drug effects, innovative technological solutions, and enhanced resources for education and enforcement. By synthesizing empirical research with expert opinion, the report provides a foundational resource for researchers, practitioners, and policymakers to develop and evaluate effective countermeasures for this under-researched public health issue.
Key finding
A scoping review and expert consultation identified approximately 60 prescription/OTC drug-impaired driving countermeasures across pharmacy, toxicology, enforcement/judicial, and education domains, but most lack rigorous empirical evaluation; patient counseling, labeling, new testing technologies, legal-system coordination, and standardized data systems emerged as especially promising priorities.
Methodology
mixed_methods
Provenance
The full processing record for this entry. Every stage of this paper's journey through the pipeline is logged — what ran, with which tool and model, how many attempts it took, and when it last completed. Discovered via bulk_ingest_aaa_foundation on 2026-05-23 (5 acquisition events logged).
| Stage | Outcome | Tool | Model | Prompt | Attempts | Completed |
|---|---|---|---|---|---|---|
| discover | success | aaa_foundation | — | — | 2 | 2026-05-23 |
| archive | success | — | — | — | 1 | 2026-05-23 |
| extract | success | cached | — | — | 2 | 2026-06-10 |
| clean | success | — | — | — | 1 | 2026-06-01 |
| chunk | success | — | — | — | 1 | 2026-06-01 |
| embed | success | — | — | — | 1 | 2026-06-02 |
| enrich | success | — | — | — | 1 | 2026-05-23 |
| promote | success | — | — | — | 1 | 2026-05-23 |
| summarize | success | llm | qwen3.6-27b-prismaquant | summ-v5 | 2 | 2026-06-10 |
| tag | success | vector_similarity | — | — | 19 | 2026-06-11 |
| verify | success | — | — | — | 2 | 2026-06-10 |
Summary generated by qwen3.6-27b-prismaquant on 2026-06-10; verification: verified.
Topics
Ranked by relevance to this paper. Hover a topic for its definition.
Information type
What kind of knowledge this paper contributes, grouped by family — independent of topic (what it is about) and method (how it was studied).
- Empirical Findings: observational prevalence